Breakouts HappenBH
Ticker⌘K
Closed
This is a preview. Unlock full access to all scanners and features. $8/month →
AMPH stock

AMPH - Amphastar Pharmaceuticals Stock Price, Chart, News and Analysis

-- --
OPEN--
HIGH--
LOW--
PREV CLOSE--
52W HIGH--
52W LOW--
Featured today in these scanners:
Market Cap$0.9B
RS Score8.17
RSI65.7
ADX12.2
Vol Ratio1.63x
Dist MA200+3.10%
5D+5.32%
1M+12.69%
3M+19.55%
6M+17.37%
52W-21.21%
Above MA50 / MA200Yes / Yes

Amphastar Pharmaceuticals, Inc. Common Stock (AMPH): What does the company do?

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable form of low molecular weight heparin for the prevention and treatment of deep vein thrombosis; and REXTOVY and Naloxone for opioid overdose. The company also provides Cortrosyn, a lyophilized power for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; and emergency syringe products, including atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate. In addition, it offers Albuterol sulfate inhalation aerosol for the treatment or prevention of bronchospasm; Iron sucrose injection, an iron replacement product for the treatment of iron deficiency anemia in patients with chronic kidney disease; Teriparatide injection for managing daily osteoporosis therapy; and Ipratropium Bromide HFA inhalation aerosol, an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease. Further, the company provides active pharmaceutical ingredient (API) products, such as Recombinant Human Insulin and porcine insulin API. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Unlock full access

Every scanner, the BH Indicator, insider and options flow, sector and industry rankings, the themes, the trading journal and the daily briefings from the Senior Analyst.

See plans →
Disclaimer

Breakouts Happen publishes market analysis and screening tools. Every idea, opinion and forecast on this site — stated or implied — is provided for informational purposes only and is not a recommendation to invest, trade or speculate in any market. Any position taken in light of the material published here is taken at your own risk, financial or otherwise. Breakouts Happen is not a registered investment advisor, and nothing on this site is an offer or solicitation to buy or sell any security.

Market data is delayed and provided for reference only. Past performance does not indicate future results.

© 2026 Breakouts Happen. All Rights Reserved. +SCAOPN Market data delayed.
ESC
Type to search stocks, ETFs, indices
We value your privacy
We use cookies to enhance your browsing experience and analyze our traffic. By clicking “Accept all”, you consent to our use of cookies. Learn more
Preference centre
When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information is mostly used to make the site work as you expect it to.
Necessary3 cookies Always active

Essential cookies for basic site functions, including your session.

Functional4 cookies

Cookies for enhanced functionality, such as your theme preference.

Analytics3 cookies

Cookies to understand site usage and improve our service.

Performance1 cookie

Cookies to improve site performance.